SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

Supernus Provides Regulatory Update for SPN-830

08 Apr 2024 08:00:16 By Nasdaq GlobeNewswire

Supernus to Participate in Two Upcoming Investor Conferences

06 Mar 2024 16:30:50 By Nasdaq GlobeNewswire

Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference

28 Feb 2024 16:30:04 By Nasdaq GlobeNewswire

Supernus Announces Fourth Quarter and Full Year 2023 Financial Results

27 Feb 2024 16:05:33 By Nasdaq GlobeNewswire

Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024

13 Feb 2024 16:05:20 By Nasdaq GlobeNewswire

Supernus Wins Infringement and Validity Case on Trokendi XR® against Torrent

05 Feb 2024 08:30:39 By Nasdaq GlobeNewswire

Supernus Announces Third Quarter 2023 Financial Results

08 Nov 2023 16:05:44 By Nasdaq GlobeNewswire

Supernus to Participate in the Jefferies London Healthcare Conference

07 Nov 2023 16:30:42 By Nasdaq GlobeNewswire

Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA

02 Nov 2023 07:00:05 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

27 Oct 2023 09:45:05 By NetDania Notify

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

26 Oct 2023 10:30:45 By NetDania Notify

Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023

25 Oct 2023 16:15:32 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

25 Oct 2023 10:14:37 By NetDania Notify

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

19 Oct 2023 10:33:46 By NetDania Notify

Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey

16 Oct 2023 17:34:21 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

13 Oct 2023 09:45:07 By NetDania Notify

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

12 Oct 2023 09:52:50 By NetDania Notify

Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device

09 Oct 2023 16:45:19 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

03 Oct 2023 10:18:22 By NetDania Notify

NetDania - New 12 months Low: SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK

02 Oct 2023 11:34:15 By NetDania Notify